There is a new age Immunomodulator substitute on the US market

April 13, 2007 - PRLog -- There is a new age Immunomodulator substitute on the US market, it is a natural capsule form food version of Licopid.
Leukomeal is a functional Medical food that very closely resembles a Russian drug except it is completely natural and has no side effects however possesses more benefits due to a higher concentration of probiotic cell wall fragments of various types instead of an isolated molecule like Licopid.
Anecdotally it has shown to improve quality of life for people with a wide variety of chronic degenerative diseases including:
•   Hepatitis C
•   Heart disease
•   Parkinson’s disease
•   Cancer
•   Diabetes
•   Chronic Fatigue Syndrome
•   And more
Some of the greatest achievements of Leukomeal include:
Reduced GGT levels in weeks; Reduced Cholesterol; Reduced Triglycerides; increased immune system… Increased levels of glutathione…
By reducing oxidative stress one can achieve a healthy and prolonged life!
This is a description of Licopid.
Although it is not available in the US, Leukomeal is a better alternative without any side effects.
Origin. Licopid is a new semisynthetic drug of natural origin. As an immunomodulator Licopid enhances suppressed immune response or, in contrast, it can suppress autoimmune reaction.
The active ingredient of Licopid was first revealed in Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of Russian Academy of Sciences, and was developed to a drug by collaborative work of the Russian and British researchers and clinicians.
Randomized double-blind clinical trials held in Russia by Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry and the Institute of Immunology in collaboration with British company Peptech (UK) met GCP (Good Clinical Practice) principles and demonstrated the following advantages of Licopid.
Advantages
•  Very effective natural immunomodulator
•  Simple and convenient application - in tablets
•  Licopid can used in combination with antibiotics and anti-viral drugs to reduce their dose without reduction in therapeutic efficacy
•  In case of resistance to or side effects of antibiotics and anti-viral drugs Licopid can use alone for therapy of infection
•  Reduction in the frequency of exacerbation in chronic diseases improves the quality of patient's life
Properties. Active ingredient: N-Acetylglucosaminyl-(β1→4)-N-acetylmuramyl-alanyl-D-isoglutamine. It represents the main fragment of bacterial cell wall.
Presentation. Tablets containing 1 mg or 10 mg of the active ingredient, 10 tablets per blister.
Mode of action. Licopid increases general resistance against pathogens by activating phagocyte cells (neutrophils and macrophages). These cells ingest and destroy pathogenic microorganisms and at the same time, they secrete cytokines, which affect T - and B - lymphocytes and thus support the development of specific immune response. In case of suppressed haemopoiesis, e.g. caused by of chemotherapy or irradiation, Licopid treatment results in not only qualitative, but also in quantitative changes in non-specific immunity, namely in rapid neutrophils count restoring.
Therapeutic use. Licopid is used in adults for correcting immune reactions as a component of the complex therapy of various diseases associated with reduction of the immune status, including acute and chronic purulent processes and inflammatory diseases; for prevention of infectious complications in post-trauma, - and postoperative period, in oncology during chemo- and radiotherapy; for treatment of tuberculosis, cervical human papilla virus infections, ophthalmic herpes infection, psoriatic erythroderma, classic, pustular and exsudative forms of psoriasis.
Side effects. Contra-indications are unknown. The raise of the body temperature up to 38° С occasionally observed after taking Licopid can not be considered as a serious side effect, but reflects the development of immune reaction.

Website: www.leukomeal.com